According to the estimations put forth by Inkwood Research, the Global Cough Syrup Market is evaluated to project a CAGR of 2.87% in terms of revenue during the forecasting years of 2021-2028.
“Browse 40 Market Data Tables and 40 Figures
spread over 186 Pages, along with an in-depth TOC on the Global Cough Syrup Market Forecast 2021-2028.”
REQUEST FREE SAMPLE LINK - https://www.inkwoodresearch.com/reports/cough-syrup-market/#request-free-sample
VIEW TABLE OF
CONTENT LINK - https://www.inkwoodresearch.com/reports/cough-syrup-market/#table-of-contents
BUY NOW- https://www.inkwoodresearch.com/reports/cough-syrup-market/
Coughing is typically caused due to respiratory issues such
as chronic obstructive pulmonary disease (COPD), asthma, pulmonary disease,
lung cancer, and chronic lung infections. Cough syrups suppress and relax mucus
in the airways, clear the congestion, and facilitate easy breathing. They also help
ease allergic indications like runny nose, sneezing, throat irritation, and watery
eyes. Furthermore, specific combination cough syrups alleviate coughs caused by
common colds, breathing illnesses, and bronchitis.
Rising
Geriatric Population to Propel Market Growth
Chronic cough is an emerging ailment across the older
population, with an increased prevalence rate and clinical heterogeneity.
Elderly patients aged 65 and over often suffer from numerous comorbidities, leading
to high clinical heterogeneity in terms of chronic cough and also pose
therapeutic and diagnostic challenges. In comparison to younger adults, elderly
patients may also be diagnosed with added chronic cough issues linked to
reflux, lung parenchymal disorders, or medications. Furthermore, asthma, upper
airway disease, and gastroesophageal reflux disease (GERD) are among the most
common conditions underlying chronic cough in the geriatric populace.
To know more about this report, request
a free sample copy.
Cough
Suppressants/Antitussives Held the Greatest Market Share in 2020
Cough suppressants, also termed antitussives, block the
cough reflex and make coughing less frequent. Dextromethorphan (DM) is a
typical active ingredient found in cough suppressants. In addition, decongestants
or antihistamines are also utilized in cough suppressants. Johnson &
Johnson, GlaxoSmithKline PLC, Proctor & Gamble Co, etc., are some of the
key companies providing cough syrups constituting cough suppressants. For instance,
Johnson & Johnson distributes Benadryl Cough Syrup, used in treating cough.
Asia-Pacific
to Lead and Dominate the Global Market by 2028
The Asia-Pacific harbors a significant, heterogeneous
population. Their respiratory health is primarily influenced by various social,
economic, as well as environmental factors. However, despite the variability,
the commonly prevalent causes of respiratory mortality and morbidity entail and
air pollution, tobacco smoking, and infection. The leading respiratory health problems
in the Asia-Pacific are smoking‐related disorders, respiratory viruses such as
influenza, air pollution, tuberculosis (TB), and occupational lung diseases.
Enterprises with undifferentiated products, in addition to larger
product portfolios, generate increased competition in the global cough syrup
market. Moreover, leading companies hold a robust geographical presence
internationally and also offer a diverse product range. As a result, the
industrial rivalry is expected to be intense in the global cough syrup market.
Some of the top firms operating in the market are
GlaxoSmithKline PLC, Johnson & Johnson, Proctor & Gamble Co, etc.
About Inkwood Research
Inkwood Research specializes in syndicated & customized
research reports and consulting services. Market intelligence studies with
relevant fact-based research are customized across industry verticals such as
technology, automotive, chemicals, materials, healthcare, and energy, with an
objective comprehension that acknowledges the business environments. Our
geographical analysis comprises North & South America, CEE, CIS, Middle East,
Europe, Asia, and Africa.
Contact Us
https://www.inkwoodresearch.com
+1 857-302-4704
Related Reports:
Comments
Post a Comment